Clinical Trials Browser

Phase 1/2 × abiraterone × 30 days × Clear all

NCT06863272 2026-03-16

IDeate-Prostate02

Phase 1/2 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT04179864 2026-03-10

CELLO-1

Phase 1/2 Terminated

102 enrolled 39 charts

Prostatic Neoplasms

NCT07190300 2026-03-02

TulmiSTAR-02

Phase 1/2 Recruiting

Bulbo-Spinal Atrophy, X-Linked